| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |